Related Articles
Comparative efficiency of differential diagnostic methods for the identification of BRAF V600E gene mutation in papillary thyroid cancer (Review)
Clinical significance of BRAF V600E mutation in 154 patients with thyroid nodules
BRAF mutations in papillary thyroid carcinoma and emerging targeted therapies (Review)
Identification of a novel HRAS variant and its association with papillary thyroid carcinoma
Mps1 is associated with the BRAFV600E mutation but does not rely on the classic RAS/RAF/MEK/ERK signaling pathway in thyroid carcinoma